Radiopharm Theranostics Ltd
RAD
Company Profile
Business description
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Contact
62 Lygon Street
Suite 1, Level 3, Carlton South
MelbourneVIC3053
AUST: +61 398245254
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Will China strong arm BHP into lower iron ore prices?
Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks
Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27
Charts from the Australian Dividend Outlook show the sectors where they are abundant.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,276.90 | 19.60 | -0.21% |
| CAC 40 | 8,060.13 | 85.28 | 1.07% |
| DAX 40 | 24,597.13 | 211.35 | 0.87% |
| Dow JONES (US) | 46,601.78 | 1.20 | -0.00% |
| FTSE 100 | 9,548.87 | 65.29 | 0.69% |
| HKSE | 26,674.51 | 154.95 | -0.58% |
| NASDAQ | 23,043.38 | 255.02 | 1.12% |
| Nikkei 225 | 48,316.83 | 581.84 | 1.22% |
| NZX 50 Index | 13,535.75 | 32.73 | -0.24% |
| S&P 500 | 6,753.72 | 39.13 | 0.58% |
| S&P/ASX 200 | 8,972.00 | 23.00 | -0.26% |
| SSE Composite Index | 3,897.18 | 14.40 | 0.37% |